Composition GLP-1 Semaglutide: 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment via HPLC/LC-MS Assay development and calibration for quantitative analysis of GLP-1 receptorrelated models Chromatographic method optimization for impurity profiling and peak resolution Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available (HPLC/LC-MS) Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
The test analyzes variants in GCLC, GCLM, and GST detoxification genes that may influence glutathione synthesis and phase II metabolism
Sigma-Aldrich) and subjected to SDS-PAGE
One small study found that GLP-1 medications helped reduce BMI in people with lupus without triggering flares
Mild gastrointestinal symptoms (nausea, reduced appetite, occasional constipation) are the most frequently reported and usually resolve within the first few weeks as the body adjusts
Ensuring adequate nutrition despite caloric restriction is importantsevere caloric deficit can exacerbate menstrual irregularities
